NR2E3 and cancer: In the in-cell CETSA experiment with thymidine, two important drug targets for cancer therapy were directly revealed; TYMS targeted by e.g. fluorouracil and diverse antifolates [65], and RNR, targeted by e.g. clofarabine and gemcitabine [66].